Andrew P. Davis
Andrew P. Davis publishes mostly in Molecular Medicine, Pharmacology and Infectious Diseases, on topics such as Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Antifungal resistance and susceptibility.
- World rank
- #3,823,306 of 7,710,434 ranked researchers
- Rank in United States
- #1,052,125 of 1,627,098
- Works
- 28
- Citations
- 508
- Citations per work
- 18.1
What does Andrew P. Davis research?
Andrew P. Davis's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (29%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1138.2%
- Everything else932.9%
- Health Sciences828.9%
- Medicine828.9%
- 1Molecular Medicine22% of their works
- 2Pharmacology12% of their works
- 3Infectious Diseases10% of their works
- 4Endocrinology8% of their works
- 5Molecular Biology8% of their works
- 6Epidemiology7% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antifungal resistance and susceptibility
- Plant Pathogenic Bacteria Studies
- Bacterial Identification and Susceptibility Testing
- Enterobacteriaceae and Cronobacter Research
- Pharmaceutical and Antibiotic Environmental Impacts
- Antimicrobial Resistance in Staphylococcus
Which keywords describe Andrew P. Davis's research?
The keywords of their largest research topics: Antibiotic Resistance, Multidrug-Resistant Bacteria, Antimicrobial Resistance, Biofilm Formation, Epidemiology, Antibiotic Pharmacokinetics, Critically Ill Patients and Virulence Factors.
- Staphylococcus aureus
- Plant Pathogenic Bacteria
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Genomics
- Cronobacter sakazakii
- Invasive Fungal Infections
- Virulence Factors
- Antibiotic Pharmacokinetics
- Biofilm Formation
- Multidrug-Resistant Bacteria
- Antibiotic Resistance
- Antimicrobial Resistance
- Epidemiology
- Critically Ill Patients
- Candidiasis
- Antibiotics
- Enterobacteriaceae
- MRSA
- Microorganism Identification
- Resistance Genes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antibiotic Resistance171 topic
- Multidrug-Resistant Bacteria171 topic
- Antimicrobial Resistance92 topics
- Biofilm Formation72 topics
- Epidemiology72 topics
- Antibiotic Pharmacokinetics61 topic
- Critically Ill Patients61 topic
- Virulence Factors62 topics
- Candidiasis41 topic
- Invasive Fungal Infections41 topic
- Antibiotics31 topic
- Cronobacter sakazakii31 topic
- Enterobacteriaceae31 topic
- Genomics31 topic
- MRSA31 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry31 topic
- Microorganism Identification31 topic
- Plant Pathogenic Bacteria31 topic
- Resistance Genes31 topic
- Staphylococcus aureus31 topic
Where does Andrew P. Davis work?
Andrew P. Davis's main affiliation in the publication record is JMI Laboratories, United States.
How many publications and citations does Andrew P. Davis have?
OpenAlex counts 28 works and 508 citations for Andrew P. Davis, an h-index of 10, ranking #3,823,306 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Andrew P. Davis
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew P. Davis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.